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Abstract: In recent years, green syntheses have been researched comprehensively to develop
inexpensive and eco-friendly approaches for the generation of nanoparticles. In this context, plant and
microbial sources are being examined to discover potential reducing agents. This study aims to utilize
an extracellular pigment produced by Talaromyces purpurogenus as a prospective reducing agent to
synthesize silver nanoparticles (AgNPs). Biosynthesized AgNPs were characterized by transmission
electron microscopy (TEM), dynamic light scattering (DLS), electron probe micro analyser (EPMA),
and zeta potential. The pigment functional groups involved in the generation of AgNPs were
investigated using Fourier transform infrared spectroscopy. TEM images showed that the generated
nanoparticles were spherical, hexagonal, rod-shaped, and triangular-shaped with a particle size
distribution from 4 to 41 nm and exhibited a surface plasmon resonance at around 410 nm. DLS
and zeta potential studies revealed that the particles were polydispersed and stable (−24.8 mV).
EPMA confirmed the presence of elemental silver in the samples. Biosynthesized AgNPs exhibited
minimum inhibitory concentrations of 32 and 4 µg/mL against E. coli and S. epidermidis, respectively.
Further, cytotoxicity of the AgNPs was investigated against human cervical cancer (HeLa), human
liver cancer (HepG2), and human embryonic kidney (HEK-293) cell lines using 5-fluorouracil as a
positive control. A significant activity was recorded against HepG2 cell line with a half-maximal
inhibitory concentration of 11.1 µg/mL.
Keywords: Talaromyces purpurogenus; silver nanoparticles; anti-cancer activity; anti-microbial activity
1. Introduction
Owing to the recent rise in the development of environment-friendly technologies, green
nanotechnology has become an area of focus, leading to an exploration of various avenues in the search
for natural reducing agents. Plants and microbes have become an essential target in this quest because
of their ubiquity. Several plant extracts such as Aloe vera [1], Piper nigrum [2], Eucalyptus globulus [3],
Sida cordofolia [4], Rosa damascena [5], and Cinnamomum camphora [6] have been used for silver
nanoparticles (AgNPs) generation. Bacteria and fungi have also been used prominently for the reduction
of metal salts to nanoparticles. Whole cells and cellular products have been used for synthesizing
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nanoparticles, such as Pseudomonas stutzeri AG259 [7], Brevibacterium casei [8], Fusarium oxysporum [9],
Aspergillus flavus [10], and cell-free extracts of Bacillus subtilis [11], Aspergillus fumigatus [12], and
Cladosporium cladosporioides [13]. Mukherjee et al. demonstrated a fungal enzymes/protein-mediated
generation of nanoparticles [14,15]. Because fungal cells can potentially produce higher amounts of
protein than that produced by bacterial cells, the potential for an enhanced yield of nanoparticles
becomes higher [16]. Extracellular components such as cell-free broth and extracts are easier to use
and can help in minimizing downstream processing.
In this light, extracellular products produced by microbial cells can help in economizing
nanoparticle synthesis because the extraction steps can be circumvented. This, in turn, puts focus on
the search for extracellular products that are inexpensive and easier to produce and purify. Therefore,
pigments derived from microbes have been recently attracting considerable attention for their reduction
ability. Monascus purpureus [17,18], Nostoc linckia, and Nostoc carneum [19,20] have been used in the
production of pigment for metallic nanoparticle generation. Red and orange monascus pigments
were used for the generation of silver and gold nanoparticles in the former studies, whereas the latter
utilized phycocyanin and phycoerythrin for silver nanoparticle generation. These studies employed
photochemical reduction for nanoparticle synthesis. The nanoparticles produced in these studies were
examined for various applications such as antimicrobial activity, biofilm inhibition, heavy metal ion
detection, and in-vitro and in-vivo anticancer activity. However, the extraction methods involve the
use of organic solvents and/or cell destruction because pigment production is, in general, intracellular.
In contrast, Talaromyces purpurogenus (T. purpurogenus) can produce a high amount of extracellular
Monascus-like pigments, which negates the need for extensive extraction procedures. Monascus-like
pigments are a group of azaphilone mixtures containing yellow, orange, and red pigments [21].
Six major monascus pigments include the following: monascin and ankaflavin for yellow pigments;
rubropunctatin and monascorubrin for orange pigments; and rubropunctamine and monascorubramine
for red pigments. Although these are fundamental pigments produced by Monascus species, more
than 50 other compounds have been identified as Monascus pigments [22]. Several researchers have
reported the production of pigments from various Talaromyces species, highlighting the fact that this
ascomycota has an ability to produce a high amount of water-soluble extracellular pigments and that
these pigments comprise of a mixture of various Monascus-like pigments [23–26].
This study attempted to exploit the reduction ability of T. purpurogenus extracellular composite
pigment for green synthesis of AgNPs. The biosynthesized AgNPs were characterized and their
biomedical applications were studied.
2. Materials and Methods
2.1. Materials
Silver nitrate (AgNO3), sucrose, yeast extract, peptone, magnesium sulphate heptahydrate
(MgSO4·7H2O), dipotassium hydrogen phosphate (K2HPO4), sodium nitrate (NaNO3) and Ethanol
(99%, special grade) were procured from Fujifilm Wako Pure Chemical Corporation, Chuo-Ku,
Osaka, Japan.
2.2. Talaromyces Purpurogenus Growth Conditions and Pigment Production
T. purpurogenus strain was acquired from Cell Cultivation Lab, Life and Environmental Sciences,
University of Tsukuba, Tsukuba, Ibaraki, Japan. Ten millilitres of spore suspension (3 × 106/mL)
was used to initiate inoculum production in preculture media. The preculture media consisted of
30 g/L sucrose, 5 g/L yeast extract, 1 g/L K2HPO4, 0.3 g/L NaNO3, 0.05 g/L KCl, 0.05 g/L MgSO4·7H2O,
and 0.001 g/L FeSO4·7H2O. Flasks were incubated at 30 ◦C and 150 rpm for 24 h in dark conditions.
Following the preparation of preculture media, the production media was prepared with the following
composition: 50 g/L sucrose, 25 g/L peptone, 2 g/L K2HPO4, 2 g/L MgSO4·7H2O, 1 g/L NaNO3, 0.05 g/L
KCl, and 0.001 g/L FeSO4·7H2O. Five percent of the inoculum volume was used to commence pigment
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production. The flasks were incubated at 30 ◦C at 150 rpm for 10 days in dark conditions. The pH
values of both preculture and production media were adjusted to 5 using 6N hydrochloric acid (HCl).
2.3. Extraction of Extracellular Pigment
The culture broth (10 mL) was centrifuged at 6700 g for 20 min to separate the extracellular
pigment from the biomass. The obtained supernatant was mixed with 70% ethanol in 1:1 ratio for 3 h.
The mixture was again centrifuged at 6700 g at 4 ◦C for 20 min to precipitate impurities and other
medium components. The supernatant containing the pigment was concentrated using a rotary vapor
evaporator, then dissolved in 70% Ethanol and filtered using a 0.45 µm filter (Advantec Toyo Kaisha,
Otowa, Tokyo, Japan). The final product was stored at 4 ◦C until further use.
2.4. AgNPs Synthesis Using Pigment
The extracted pigment was used to produce AgNPs. In brief, a 5 mL reaction mixture containing
0.5 g/L pigment and 2 mM of AgNO3 was prepared. Before the addition of an AgNO3 precursor, the
pH of this mixture was adjusted to 12 using a 5 N sodium hydroxide (NaOH) solution. The obtained
reaction mixture was vortexed gently for uniform mixing and was incubated at 28 ◦C with 2000 lux
of light for 48 h. Afterwards, nanoparticle generation was verified by visual change of colour and
UV-Visible spectroscopy (V-550 spectrophotometer, JASCO, Hachioji, Tokyo, Japan). A silver nitrate
solution without the pigment and 0.5 g/L pigment solution without the precursor salt were used as
controls. The samples were diluted 30 times before performing the analysis.
2.5. Optimization of Nanoparticle Production
This experiment was performed to identify the maximum amount of AgNO3 that can be reduced
by 0.5 g/L pigment and the time required for reduction. To determine the optimum precursor
concentration, a 20 mL reaction mixture containing the pigment and various AgNO3 concentrations
between 2 mM to 20 mM was prepared in 50 mL Erlenmeyer flasks. The data were expressed in terms
of absorption maxima (Amax), wavelength maxima (λmax), and full width at half maxima (FWHM),
which represent the spectroscopic yield, size, and size distribution or polydispersity, respectively [27].
A time course study was conducted to estimate the time required for complete reduction of bulk silver.
Reaction time is an important factor in the morphology of the nanoparticles being generated. During
the crystal growth, the particles may fuse together to give rise to various morphologies. Therefore, the
determination of the optimum reaction time becomes essential. For the time course study, a 25 mL
reaction mixture containing 0.5 g/L pigment and optimum concentration of AgNO3 was prepared
in a conical flask and samples were withdrawn at 0, 2, 4, 6, 12, 24, and 36 h. These samples were
diluted 60 times before performing UV-Vis spectroscopy analysis to ensure that the maximum value of
absorption remains less than two, and the spectra were normalized to determine the FWHM values.
2.6. Characterization of Produced Nanoparticles
The produced nanoparticle suspension was centrifuged at 8400 g for 10 min, and the resultant
pellet was washed twice with Milli-Q water. The final pellet was dissolved in Milli-Q water and
kept at 4 ◦C. A part of the purified nanoparticles was lyophilized to estimate the dry weight. Several
techniques were used for the characterization of the nanoparticles. UV-Visible spectroscopy was
performed to detect the presence of nanoparticles; transmission electron microscopy (TEM) and
dynamic light scattering (DLS) were conducted to estimate the particle size; Fourier transform infrared
(FTIR) spectroscopy was carried out for identification of the pigment functional groups involved in the
reduction of bulk silver; electron probe microanalysis (EPMA) was performed to detect the existence of
silver in the nanoparticles; and zeta potential was investigated to estimate the stability of the colloidal
suspension of particles.
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2.6.1. TEM
A carbon-coated formvar film was used to prepare nanoparticle samples for TEM analysis. The
samples deposited on formvar film were air dried and placed on a copper grid for imaging under a
JEOL JEM-2100F transmission electron microscope (Akishima, Tokyo, Japan) at 200 kV.
2.6.2. DLS and Zeta Potential Measurements
A Nano ZS Zetasizer (Malvern Panalytical, Malvern, Worcestershire, UK) was used for measuring
the size distribution of the nanoparticle suspensions by DLS and for calculating zeta potential to
evaluate the stability of the nanoparticle suspensions. For the analysis of DLS and zeta potential, 3 mL
of the nanoparticle suspension was used.
2.6.3. FTIR Spectroscopy
FTIR spectroscopy was performed using a JASCO-FT/IR-6800 spectrophotometer (Hachioji, Tokyo,
Japan) over the wavenumber range of 4000–800 cm−1. The lyophilized samples were mixed with
potassium bromide (KBr) to form pellets for analysis.
2.6.4. EPMA
A JEOL JXA-8530F electron probe micro-analyser (Akishima, Tokyo, Japan) was used for
wavelength dispersive spectroscopy (WDS) for composition analysis. WDS measurements are
established using Bragg’s law and require the use of multiple crystals as monochromators. The samples
were dropped on a coverslip and air dried. Before analysis, the samples were covered with carbon and
mounted on a copper grid.
2.7. Determination of Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal
Concentration (MBC)
MIC and MBC of AgNPs were determined against Gram-positive and Gram-negative
microorganisms, namely Staphylococcus epidermidis NBRC100911 (S. epidermidis) and Escherichia coli
K 12 (E. coli), respectively. The broth microdilution method, performed in a 96-well microplate, was
employed with some modifications [28]. Nutrient broth was used to cultivate S. epidermidis, whereas LB
broth was used for E. coli. Both cultivation media were procured from Difco Laboratories Inc., Sparks,
MD, USA. AgNPs were tested for concentrations of 0.5–256 µg/mL. Streptomycin was used at the same
concentrations as the positive control. Microbial cells were also exposed to the pigment concentration
of 1–512 µg/mL to detect any antimicrobial activity. In brief, three to five morphologically-alike
colonies grown at 37 ◦C for 24 h on agar plates were picked up and transferred to sterile fresh broth.
This suspension was vortexed briefly to ensure uniform mixing, and the suspension turbidity was
adjusted to 0.5 McFarland standard (OD625  0.08–0.13). The bacterial suspension was diluted 100 times
before inoculating with the test/control substance in 1:1 ratio, resulting in a final concentration of
5 × 105 cells/mL. The final volume of the test solution in the 96-well plate was 100 µL, and the last two
rows were employed as growth control and sterility control, respectively. Growth control was used
to observe the growth of organisms without AgNPs or streptomycin, whereas sterility control was
employed to ensure that there was no contamination. The 96-well plates were then incubated at 37 ◦C
for 24 h. The lowest concentration which exhibited no visible growth compared to the control wells
was considered the MIC value. To determine the MBC, the suspensions with concentrations higher
than the MIC values were plated to check for cell survival, and the least concentration displaying no
cell survival was deemed to be MBC. All the experiments were performed in triplicates.
2.8. Cell Death Kinetics Study
S. epidermidis was used to study the cell death kinetics. Initial inoculum containing
1 × 106 cells/mL was exposed to the MBC dosages of AgNPs and streptomycin in a 96-well plate
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containing the nutrient broth. The plate was incubated at 37 ◦C, and the cells were plated at 0, 1, 2, 4, 6,
12, 24, 36, and 48 h in triplicates. The cell count was established, and the data was plotted in terms of
the log of colony-forming units per millilitre log10(CFU/mL) with respect to time to investigate the cell
death kinetics.
2.9. Anti-Cancer Activity of Biogenic AgNPs
Cytotoxic activity of biogenic silver nanoparticles was tested against cancerous cell lines HeLa
(cervical cancer), HepG2 (Hepatocellular carcinoma) and a non-cancerous cell line HEK-293 (Human
embryonic kidney) acting as a control to identify the selectivity of AgNPs. All the cell lines were
purchased from JCRB Cell Bank, National Institutes of Biomedical Innovation, Health and Nutrition,
Osaka, Japan. 5-Fluorouracil (5-FU), an established anticancer drug, was employed as a positive
control [29,30]. The cell lines were also exposed to 500 µg/mL pigment to explore the antiproliferative
effect of pigment, if any. Cells were cultured in a collagen-coated 96-well microplate in triplicate to
ensure adhesion and proliferation, seeded at a density of 25,000 cells/well, and incubated at 37 ◦C
under 5% CO2. HepG2 and HEK-293 cells were cultivated in Dulbecco’s Modified Eagle Medium
(DMEM) containing 10% foetal calf serum and 100 µg/mL of penicillin/streptomycin, whereas the
HeLa cell line was grown in Ham’s F-12 (10% foetal calf serum) medium. These cells were grown to
reach 70% confluency before being exposed to varying concentrations of AgNPs in triplicates from
25 µg/mL to 200 µg/mL. The cell line most affected by the AgNPs was selected for further testing, and
the test concentrations were varied from 3.9 µg/mL to 500 µg/mL and 1.5675 µg/mL to 200 µg/mL
of 5-FU and AgNPs, respectively. The plates were incubated for 24 h; and then cell counting kit-8
assay (CCK-8, Dojindo Molecular Technology) was performed to measure the cytotoxic activity of
AgNPs by determining the absorbance at 450 nm. The assay was performed in accordance with the
manufacturer’s protocol. The data obtained were fitted with a four-parameter logistic model using
ImageJ software (Version 1.42 q, National Institute of Health, Bethesda, MD, USA).
3. Results and Discussion
3.1. Silver Nanoparticle Synthesis
The reduction of silver nitrate to AgNPs using the composite pigment was first observed visually
and then spectrophotometrically. The colour of the solution gradually changed from light orange to
brown, demonstrating the reduction of silver nitrate (Figure 1a,b). The UV-visible spectrum of the
solution exhibited a peak near 410 nm, which is a signature peak for the surface plasmon resonance (SPR)
of AgNPs (Figure 1). SPR occurs when conduction electrons on the surface of metallic nanoparticles
are excited by a specific wavelength and start oscillating, causing a high absorption or scattering. The
diluted synthesized suspension was yellow, which further indicated the presence of AgNPs (Figure 1c).
The nanoparticle production by the composite pigment in the presence of light is plausibly due to
photolysis wherein light acts as a catalyst, inducing electron transfer and prompting the reduction of
metal salt [17,19].
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Figure 1. UV-Vis spectrum for AgNPs production using extracellular pigment of T. purpurogenus
(samples were diluted 30 times for analysis). Inset: (a) Pigment, (b) Reaction mixture after synthesis,
(c) Synthesized AgNPs diluted 30 times.
3.2. Optimization of Nanoparticle Production
3.2.1. Effect of Precursor Concentration
Precursor concentration plays an important role in the reduction process because it can be
one of the limiting factors in nanoparticle synthesis. Since a pigment concentration of 0.5 g/L was
consistently used in this study, the amount of precursor that could be reduced to nanoparticles and
stabilized by the pigment had to be optimized. The AgNO3 concentration was varied from 2 mM
to 20 mM. Although change in SPR due to increase in particle size could be discerned in an AgNO3
concentration-dependent manner (Inset in Figure 2), UV-visible spectrum of AgNPs prepared with
different precursor concentrations showed that the AgNPs production increased steadily till 8 mM
and started reducing from 10 mM (Figure 2, Table 1). This suggests that at precursor concentrations
below 8 mM, the 0.5 g/L pigment reduced the precursor entirely to AgNPs, but at higher precursor
concentrations, AgNO3 was not completely reduced by the pigment, leading to the generation of
larger sizes of AgNPs due to the aggregation of AgNPs with unreacted AgNO3. Moreover, the AgNP
suspensions generated from 8 mM onwards were not found to be stable during storage. Since the
reduction ability of pigment was intact till 8 mM, the aggregation could have occurred due to a lack of
stabilizing agents with respect to the number of particles being produced. Possibly, stabilizers such as
surfactants like cetyltrimethylammonium bromide (CTAB) could be introduced at higher precursor
concentrations to further improve the stability and yield of the process. A positively-charged surfactant
such as CTAB can create a micelle cluster in the vicinity of negatively-charged AgNPs, averting their
aggregation [31]. In comparison with other precursor concentrations, the FWHM values increased
considerably at 10 mM, 15 mM and 20 mM, indicating an increase in size polydispersity of the product.
To reconcile high yield, small particle size, and stability, therefore, 6 mM AgNO3 together with 0.5 g/L
pigment was chosen to be optimal for AgNPs production. The yield at 6 mM concentration was lesser
than that at 8 mM concentration, but the final product generated was more stable and could be stored
for a longer period of time without the risk of aggregation.
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Figure 2. UV-Vis spectra of AgNPs generated from different precursor concentrations (samples
were diluted 60 times). Inset shows changes in SPR, indicating an increase in size with increasing
concentration. AgNPs diluted 30 times produced from 2, 4, 6, 8, 10, 15, and 20 mM precursor
concentration (from left to right).
Table 1. Characteristics of AgNPs synthesized at various precursor concentrations. Samples were
diluted 60 times.
AgNO3 Concentration (mM) Amax λmax FWHM
2 0.51 413 90
4 0.89 411 82
6 1.25 414 84
8 1.55 414 81
10 1.34 415 105
15 1.04 423 154
20 0.83 431 199
3.2.2. Time Course Study
The time course experiment was performed to ascertain the appropriate reduction time required
for the generation of AgNPs. Since 6 mM was determined as the optimal precursor concentration in
the earlier experiment, the same was used in this study. The UV-Vis spectrum was recorded after every
few hours to check the progress of the synthesis. The increase in absorption of UV-Vis spectrum with
time is shown in Figure 3. The synthesis of nanoparticles rapidly progressed for the first 6 h and then
the increase was very subtle. After 12 h, the absorbance increased slightly, thereby indicating that
the reaction was coming to an end. Therefore, it can be concluded that near-complete reduction was
achieved at around 24 h, as judged by the very slight increase in absorbance at later stages around 36 h.
No significant changes were observed in the UV-Vis spectrum thereafter. Thus, 24 h was considered the
minimum time required to achieve an acceptable degree of reduction for AgNP production. Following
the optimization studies, 6 mM AgNO3 and 24 h were chosen as the optimum precursor concentration
and time, respectively. All further experiments were performed with the nanoparticles obtained using
the optimum conditions along with 0.5 g/L pigment.
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Figure 3. Time course study for generation of AgNPs at 6 mM AgNO3 and 0.5 g/L pigment at pH 12.
Samples were diluted 60 times.
3.3. Characterization of Produced Nanoparticles
3.3.1. Size Estimation by TEM and DLS
TEM analysis illustrated a distribution of spherical, hexagonal, rod-shaped and triangular-shaped
particles ranging from 4 to 41 nm (Figure 4a,b).
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Hydrodynamic size estimation of hypothetical spheres by DLS using number distribution with
respect to size shows the existence of nanoparticles from 4 to 60 nm. DLS data also indicates the
presence of a higher number of particles within 10 nm range and a lesser number of larger particles
(Figure 5), which resembles the TEM distribution quite closely. The polydispersity index value (PDI) of
suspension was found to be 0.547, which is well below the acceptable range of 0.7. PDI values are
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dimensionless, ranging from 0 to 1; values lower than 0.05 indicate a monodispersed sample, whereas
values higher than 0.7 indicate a broad particle size distribution.
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The vibration bands of -OH, amide group, -CH bending, and C-O/primary alcohol groups 
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3.3.2. FTIR Analysis
FTIR examination was carried out to determine the functional groups present in the pigment,
which may have played a vital part in the reduction and capping of AgNPs. Because AgNPs were
generated in alkaline conditions, FTIR analysis was performed for the pigment without a pH change,
as well as for the pigment at pH 12 to comprehend the change caused by the increased pH (Figure 6a).
Table 2 provides information regarding the peaks found in FTIR analysis and their functional groups.
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Table 2. Peaks obtained by FTIR analysis and corresponding functional groups.
Pigment Pigment—pH 12
Peak (cm−1) Functional Group Peak (cm−1) Functional Group
3386.39 Broad H-bonded -OH stretching 3432.67 broad -OH bending
2931.27 =CH2 asymmetric stretching 2931.27 =CH2 asymmetric stretching
1643.05 amide I/-NH bending 1774.19 -C=O group
1542.77 amide II 1658.48 amide group
1457.92 -CH bending 1450.21 strong methylene -CH bending
1388.50 phenol/-OH bending 1072.23 C-O stretch/primary alcoholstretching
1211.08 phenol/C-O- stretching 879.38 -CH vibrations
1056.80 primary alcohol/C-O- stretching
The vibration bands of -OH, amide group, -CH bending, and C-O/primary alcohol groups shifted
in the FTIR spectrum of the pigment at pH 12, whereas the =CH2 asymmetric stretching band was
present in the spectra of both the samples. At alkaline pH, new bands appeared at 1774.19 and
879.38 cm−1, and the -CH2 bending vibration peak became very strong; however, bands corresponding
to amide II, C-O, and primary alcohol groups at 1542.77, 1388.50, and 1211.08 cm−1, respectively,
disappeared. Therefore, it can be argued that the properties of functional groups of the pigment
changed depending on the pH value. The visual change in colour of the pigment at a pH of 12 also
evidences the change in optical and absorption properties (Figure 6b, inset). In addition, the UV-Vis
spectrum clearly shows shifts in peaks, thereby indicating changes in its functional groups at high pH
values. Verma and Mehata (2016) showed that the Azadiractha indica extract at pH 13 could reduce the
precursor to AgNPs [32]. They concluded that this might be due to an increase in the bioavailability
of functional groups in the reaction mixture caused by the change in pH and could be the reason
for effective synthesis. In this study, the changes in FTIR spectra and UV-Vis spectra might indicate
increased bioavailability, leading to increased reduction ability of functional groups. Nevertheless, the
difference in the reduction activity cannot be solely explained by these changes. Previously, NaOH
was revealed as an accelerator in the AgNP generation process. Nishimura et al. (2011) showed that
NaOH not only plays an important role in the formation of intermediates in Ag+ reduction, but also
increases the reduction and nucleation rates by oxidizing the reducing agent itself, while using sodium
acrylate as a reducing as well as capping agent [33]. Similarly, these factors might account for the better
generation of AgNPs by the pigment in alkaline conditions. Further study is essential to realize the
mechanisms involved in this process.
The presence of -OH groups along with phenolic/alcoholic groups, and C–O groups with amide
groups have been known to induce reduction and stabilization/capping, respectively [34,35]. Phenolic
groups take part in redox reactions, which leads to the generation of quinones and donating electrons.
These electrons in turn reduce the metal ions to nanoparticles [36]. These groups might also be involved
in this reduction process too. Since the synthesis of AgNPs is mediated by bioactive groups, they can
possibly be utilized in biomedical applications.
3.3.3. EPMA
The EPMA data qualitatively indicates the existence of elemental silver in the sample (Figure 7).
The EPMA maps clearly show the presence of silver in the targeted part of the sample along with other
impurities that can be observed in the background. The colour scale represents the relative content of
elements present in the targeted sample area. EPMA mapping detected the presence of AgNPs in areas
where the sample is present. This is evident in the corresponding scanning micrograph image (SL in
Figure 7). The semi-quantitative data and the comparison of the sample with background data for the
targeted area are provided as supplementary material (Figure S1 and Table S1).
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3.3.4. Zeta Potential
The zeta potential of the purified nanoparticles was determined to be −24.8 ± 7.2 mV with a
conductivity of 0.0119 mS/cm, indicating a moderately stable suspension (Figure 8). The biogenic
AgNPs carry an anionic charge on their surface, which could play an important role in their biological
activity. Since most cellular membranes are negatively charg d, t e surfac charg m y affect the
interaction of nanoparticles with th membranes. Positively charged nanoparticles exhibit higher
cytotoxicity f r the same reason [37]. In a stable colloidal system, the surfac effects are more dominant
than the bulk effects; therefore, stability depends on factors such as electrostatic interactions, surface
charges on the particle, properties of the solvent, and van der Waals forces. The zeta potential of the
suspension indicates stability by electrostatic repulsion, as it measures the effective charge present on
the nanoparticle surface. The value of zeta potential was estimated by measuring the electrophoretic
mobility. For suspensions stabilized only by electrostatic repulsion, suspensions with a zeta potential
of ±30 mV are generally treated as highly stable, whereas for suspensions stabilized by steric repulsion,
a zeta potential value of ±20 mV is usually accepted as stable [19,38].
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3.4. MIC and MBC Studies
The anti-microbial activity of the biogenic AgNPs was assessed against a Gram-positive bacterium
(E. coli) and a Gram-negative bacterium (S. epidermidis) by the MIC method. The minimum concentration
of AgNPs required to cause inhibition as well as cell death was noted and compared with that of a
standard broad-spectrum antibiotic, streptomycin (Table 3). The pigment showed no inhibitory activity
at the tested concentrations against either organism. AgNPs seemed to exhibit superior activity against
Gram-positive bacteria than against Gram-negative bacteria, which is contrary to the theory that owing
to the different cell wall characteristics, AgNPs are less effective towards Gram-positive bacteria than
towards Gram-negative bacteria [39]. Gram-negative cells are more vulnerable to AgNPs due to the
presence of lipopolysaccharides on their surface that carry a negative charge; this results in higher
interaction with the positive silver ions, that eventually results in the degradation of the cell wall.
In this case, the stronger action against a Gram-positive bacterium might be due to the presence of
bioactive functional groups on the surface of AgNPs. It might also be a case of strain specificity, that is,
this particular strain of S. epidermidis is more susceptible to the antibacterial action of bio-coated AgNPs.
Table 3. MIC and MBC values for AgNPs and Streptomycin.
Organism Sample MIC (µg/mL) MBC (µg/mL)
E. coli
AgNPs 32 64
Streptomycin 8 32
S. epidermidis AgNPs 4 32
Streptomycin <0.5 2
Several concerted mechanisms are responsible for the cytotoxic action of AgNPs against bacterial
cells. These mechanisms include the disintegration of cell walls by physical interaction with AgNPs
and Ag+ ions, followed by the leakage of intracellular components; denaturation of proteins and
enzymes by the ions released from AgNPs, leading to the cessation of adenosine triphosphate (ATP)
production; and the interaction with DNA and consequent production of reactive oxygen species
(ROS), which come in contact with the ribosomes and decrease their activity (Figure 9) [40–43]. AgNPs
might also be able to impede cell respiration by reacting with oxygen and sulfhydryl groups present
atop the cell surface, leading to ATP depletion and cell death [44]. In contrast, streptomycin inhibits
bacterial cell proliferation by attaching to the 16S rRNA of the 30S subunit, thereby leading to the
inhibition of protein synthesis. Other researches have shown that the nanoparticle size is an important
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factor in terms of penetration power and interaction with the cell membrane [45]. With increasing
cases of antibiotic resistance, AgNPs might be able to provide a potential alternative to conventional
anti-microbial agents.
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Figure 9. Putative concerted mechanistic model of antibacterial action of AgNPs showing the interaction
of AgNPs and silver ions (Ag+) with cell membrane, ribosomes, proteins, and DNA leading to ROS
production and consequent cell death.
3.5. Microbi l Cell-Death Kinetics Stu y
The microbial cell death kinetics study was conducted at the MBC, the concentration at which
cell death occurs. The concentrations of AgNPs and streptomycin used were 32 µg/mL and 2 µg/mL,
respectively. The initial cell concentration was 1 × 106 cells/mL. Streptomycin exhibited a faster mode of
action compared to AgNPs, reaching zero CFU count in 12 h, while AgNPs required approximately 24 h
to reach zero CFU count (Figure 10). In contrast, the control cells achieved a robust growth, entering
the log phase after 6 h and the stationary phase after 24 h. The decrease in CFU count for streptomycin
was evident only after 2 h, whereas the initial decrease in the case of AgNPs was clearly evident after
6 h. Bactericidal action can be represented in terms of logarithmic reduction, which correlates the CFU
of the untreated cells with that of the treated cells. A reduction of greater than 3 log10 compared with
the initial inoculum can be treated as evidence of bactericidal action [46]. In the case of streptomycin,
this reduction was achieved between 6 and 12 h, whereas the AgNPs reached this reduction between
12 and 24 h. The final cell count in both the cases was found to be zero in 1:10 dilution. The data was
treated accordingly, assuming the pr sence of 10 viable cells i the sample, giving t final log10(CFU)
value as 1. Although AgNPs exhibited slower b teric da kinetics compa d with streptomycin,
they both eventually resulted in cell death. As such, in future, it might be prudent to use AgNPs in
conjunction with standard antibiotics, so that the efficiency of traditional antibiotics can be merged
with the penetration ability of AgNPs along with their own antibacterial ability.
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Figure 10. Cell death kinetics for S. epidermidis. Error bars represent standard deviation (n = 3).
A 32 refers to the MBC dosage for AgNPs (32 µg/mL) and S2 refers to the MBC dosage of streptomycin
(2 µg/mL). Control refers to cells grown without AgNPs/Streptomycin.
3.6. Anti-Cancer Activity of Biogenic AgNPs
Recently, researchers have shown that due to their unique properties, AgNPs possess a therapeutic
potential that can be utilized in cancer treatment. Figure 11a shows that, with an increase in nanoparticle
concentration, the cell survival decreased for all the cell lines, indicating the cytotoxic effect of AgNPs
on cell population. In addition, the data shows that compared to HeLa and HepG2, HEK-293 was more
resistant to these effects than HeLa and HepG2, since more than 60% of HEK-293 survived exposure to
AgNPs concentration of 100 µg/mL. This indicates that AgNPs are somewhat selective towards cancer
cell lines. The nanoparticles affected HepG2 most strongly. Therefore, the HepG2 cell line was selected
for studying the anti-cancer activity of AgNPs further in detail. The pigment at 500 µg/mL exhibited
no antiproliferative activity against the HEK-293 and HeLa cell line (Figure S2 (I,III)), whereas a weak
activity was detected against the HepG2 cell line, where cell survival was almost 80% after exposure to
pigment (Figure S2 (II)). No discernible change was observed in the cell morphology after exposure to
pigment in any cell line. T e presence of bioactive ligands responsible for pigment’s weak cytotoxic
activity on the surfac of nanoparticles could explain the strong activity of bioge ic AgNPs against the
HepG2 cell line.
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Figure 11. (a) Anticancer activity of biofunctionalized AgNPs against various cell lines. (b) Effect
of AgNPs on HepG2 cell line. (c) Effect of 5-FU on HepG2 cell line. Error bars represent standard
deviation (n = 3).
A four-parameter logistic model curve was plotted using the data obtained after exposing the
HepG2 cell lines to various dosages of 5-FU and AgNPs. This curve is useful for biological models
such as dose-response and receptor–ligand binding assays. The curve was used to calculate the values
of the half-maximal inhibitory concentration (IC50), which refers to the concentration of the drug
required for 50% cell death. The IC50 value of AgNPs (~11.1 µg/mL) was found to be lower than that
of 5-FU (154.88 µg/mL), thereby indicating that AgNPs demonstrated a much stronger action against
HepG2 cells compared to 5-FU (Figure 11b,c). Figure 12 shows the changes in cell morphology. At high
concentrations of 5-FU, almost all the cells are dead, spherical and floating, as compared to the control
where the cells are attached to the surface. In the case of AgNPs, the dead cells appear damaged by
AgNPs as they exhibit an irregular shape and are clumped together. This might be due to the difference
in the mode of action of the two samples. 5-FU mainly acts as a thymidylate synthase inhibitor that
interrupts the DNA replication. In contrast, AgNPs seem to have interacted with the cell membrane,
causing disruption apart from its other modes of action. As the dosage of both 5-FU and AgNPs is
decreased, the cells exhibit a comparably healthier growth which is evident from cell morphology at
concentrations of 31.25 µg/mL and 12.5 µg/mL for 5-FU and AgNPs, respectively. At a mid-level dosage
of 125 µg/mL for 5-FU, although the cell growth seems less dense compared to the control, the cells are
still alive; however, for 50 µg/mL of AgNPs dosage, the cells are dead. This can be corroborated with
the cell survival values shown in the curve. The images clearly depict the effect of 5-FU and AgNPs on
the HepG2 cell line in a dose-dependent manner. Coupled with the selectivity shown against HEK-293,
the results suggest that AgNPs might have a window of opportunity to selectively act against cancer
cell lines.
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and AgNPs (bottom).
Previously, the researchers have speculated that the primary manner of action of AgNPs could
be the interaction of released ions with the cellular co ponents, leading to the production of ROS
and oxidative stress that causes apoptotic cell eath [47]. In addition, this interaction reduces ATP
production a d disrupts the functioning of cellular proteins a d e zymes such as protein kinase, thereby
interfering with cell repair [48]. Apa t from this, AgNPs have been s own to constrain angiogenesis,
which is a es ential step in tumour growth and metastasis [49]. These diver e mechanisms might act
in concert for the AgNPs to exert their anti-cancer poten ial.
The activity of biogenic AgNPs against several cancerous cell lin s has been previously reported.
El-Naggar et al. [19] prepared phycocyanin-reduced AgNPs that had an IC50 value of 27.79 ± 2.3 µg/mL
against ma mary gland breast cancer (MCF-7), 31.78 ± 2.2 µg/mL against hu an lung fibroblast (WI38)
cell line, and 32.97± 1.7µg/mL against human amnion (WISH) cell lines. Similarly, Anbazhagan et al. [50]
synthesized AgNPs using Cunninghamella echinulata and tested their cytotoxicity against Vero cell
lines, which showed an IC50 value of 62.8 µg/mL for AgNPs. This activity was contrasted against the
cytotoxic activity of AgNO3, which indicated that myco-synthesized nanoparticles were less cytotoxic
to normal cells than bulk salts. AgNPs synthesized using Klebsiella oxytoca DSM 29614 were coated
with exopolysaccharides under the presence and absence of oxygen. The AgNPs synthesized under
aerobic conditions exhibited very strong activity against human breast cancer cell lines, SKBR3 and
8701-BC, with IC50 values of 5 µg/mL and 8 µg/mL, respectively [51]. In addition, they exhibited IC50
values of 20 ± 2, 26 ± 2, and 34 ± 4 µg/mL against human colon cancer cell lines, HT-29, HCT 116, and
Caco-2, respectively [51].
Ahmadian et al. [52] showed that chemically produced AgNPs have an IC50 value of 75 µg/mL
against the HepG2 cell line. In contrast, Justin Packia Jacob et al. [53] estimated an IC50 of 31.25 µg/mL
against H pG2 cells for AgNPs prepared by reduction using Piper longum leaf xtracts and hypothesized
that this action might be attributed to piperidine pr sent in the leaf extract coating the AgNP surface.
These resu ts indicate that the properties of AgNPs gen rated from reduction using biological
compounds might be different from that of the chemically sy thesiz d AgNPs. Moreover, the
difference in the nature of bio-reductant imparts different properties to the synthesized nanoparticles.
In this study, AgNPs exhibited an IC50 value of 11.1 µg/mL, signifying a very strong activity against
HepG2 cell lines. This activity is quite comparable to the other values mentioned in the literature. The
functional groups and molecules present on the AgNPs surface in conjunction with the penetrative
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power of nanoparticles, might be responsible for the potent anti-cancer activity of AgNPs produced in
this study. Collectively, the data suggests that biogenic AgNPs derived in this study can potentially
inhibit cancer cell growth. Although the initial results seem promising, further studies on the mode of
action and selectivity of AgNPs are required before AgNPs can be proposed as a suitable addition in
the armoury against cancer cells.
4. Conclusions
The extracellular pigment of T. purpurogenus was successfully utilized as a reducing agent to
bio-synthesize AgNPs. A low pigment concentration of 0.5 g/L was required, which provides scope for
scalability of the synthesis process. The optimum precursor concentration and reduction time were
found to be 6 mM and 24 h, respectively. Characterization of the nanoparticles revealed their size to be
in range of 4 to 41 nm. Further exploration is needed to understand the process of AgNP synthesis.
The FTIR spectra of the pigment in natural and alkaline conditions were compared to understand
the groups involved in the reduction mechanism, and the anti-microbial and anti-cancer activities of
the biofunctionalized AgNPs were evaluated. The anti-microbial activity was detected to be more
significant against Gram-positive S. epidermidis, which was ascribed to the presence of functional
groups coating the exterior surface of the nanoparticles. Further research can be conducted for various
combinations of antibiotics and AgNPs to understand their synergistic potential in the face of rising
antibiotic resistance. The strong activity of the biofunctionalized AgNPs against HepG2 cancer cell line
was also attributed to the molecules coating the nanoparticle surface. The mode of action of biogenic
AgNPs and the reasons behind selectivity are still unclear and can be studied in detail in the future.
More research is required to understand the molecules and functional groups present in the pigment,
and to unearth other probable applications of the pigment-mediated biosynthesized AgNPs.
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morphology after exposure to pigment.
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